COM:CLOVERHEALTH
Clover Health
- Stock
Last Close
3.36
22/11 21:00
Market Cap
665.23M
Beta: -
Volume Today
3.90M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|
average inventory | -76.96M - | -127.90M 66.19% | ||||
average payables | 14.06M - | 30.29M 115.34% | ||||
average receivables | 31.16M - | 104.74M 236.12% | ||||
book value per share | -0.00 - | -1.41 3,223,670.63% | 1.15 181.50% | 0.73 36.25% | ||
capex per share | -0.00 - | -0.00 - | -0.01 510.85% | |||
capex to depreciation | -0.04 - | -0.58 - | -3.76 548.55% | |||
capex to operating cash flow | 0.00 - | 0.00 - | 0.02 755.37% | |||
capex to revenue | -0.00 - | -0.00 - | -0.00 161.59% | |||
cash per share | 0.37 - | 1.31 249.75% | 0.70 46.21% | |||
days of inventory on hand | -36.22 - | -10.77 70.27% | ||||
days payables outstanding | 6.62 - | 3.43 48.20% | ||||
days sales outstanding | 15.45 - | 15.45 0.03% | ||||
debt to assets | 0.00 - | 0.03 870.17% | 0.01 75.24% | |||
debt to equity | -0.00 - | 0.05 3,737.61% | 0.02 67.34% | |||
dividend yield | 0.00 - | |||||
earnings yield | -0.10 - | -0.02 77.55% | -0.35 1,474.69% | -0.69 99.85% | -0.46 32.63% | |
enterprise value | 4.13B - | 6.76B 63.75% | 1.48B 78.10% | 344.74M 76.70% | ||
enterprise value over ebitda | -22.59 - | -73.31 224.56% | -2.33 96.83% | -0.93 59.93% | ||
ev to operating cash flow | -25.80 - | -3.03K 11,655.07% | -5.24 99.83% | -1.69 67.74% | ||
ev to sales | 8.92 - | 10.04 12.50% | 1.01 89.99% | 0.10 90.13% | ||
free cash flow per share | -0.40 - | -0.01 98.61% | -0.60 10,816.63% | -0.44 27.21% | -0.29 33.20% | |
free cash flow yield | -0.04 - | -0.00 99.15% | -0.16 49,112.87% | -0.47 191.32% | -0.31 34.79% | |
graham net net | -0.00 - | -1.69 580,124.96% | 0.37 121.78% | -0.14 137.99% | ||
graham number | 0.03 - | 3.41 10,808.76% | 5.75 68.73% | 3.25 43.58% | ||
income quality | 0.44 - | 0.33 24.88% | 0.48 45.47% | 0.60 25.29% | ||
intangibles to total assets | 0 - | 0 | 0.00 Infinity% | 0.02 455.56% | 0 100% | |
interest coverage | -4.69 - | -1.62 65.38% | -37.67 2,220.46% | -272.14 622.43% | -29.79K 10,847.28% | |
interest debt per share | 0.10 - | 0.14 48.24% | 0.10 33.65% | 0.02 84.04% | ||
inventory turnover | -10.08 - | -33.90 236.38% | ||||
invested capital | -0.00 - | 0.05 3,737.61% | 0.02 67.34% | |||
market cap | 4.13B - | 6.78B 64.41% | 1.75B 74.18% | 442.67M 74.73% | 459.08M 3.71% | |
net current asset value | -117.98K - | -807.33M 684,213.12% | 341.06M 142.25% | 164.12M 51.88% | ||
net debt to ebitda | 0.30 - | 0.43 45.04% | 0.26 38.12% | |||
net income per share | -1.00 - | -0.37 63.09% | -1.28 249.30% | -0.64 50.06% | -0.44 31.00% | |
operating cash flow per share | -0.40 - | -0.01 98.61% | -0.60 10,788.75% | -0.43 28.59% | -0.29 31.74% | |
payables turnover | 55.15 - | 106.46 93.05% | ||||
receivables turnover | 23.62 - | 23.63 0.03% | ||||
research and ddevelopement to revenue | ||||||
return on tangible assets | -4.01K - | -0.56 99.99% | -0.64 14.82% | -0.39 39.38% | ||
revenue per share | 1.14 - | 1.66 45.56% | 3.13 87.90% | 7.30 133.51% | 4.22 42.22% | |
roe | 22.85K - | 0.26 100.00% | -1.12 528.58% | -0.88 21.67% | ||
roic | 11.51K - | 0.27 100.00% | -1.14 529.73% | -0.93 18.39% | ||
sales general and administrative to revenue | 0.41 - | 0.28 29.70% | 0.30 6.29% | 0.14 53.78% | 0.09 34.11% | |
shareholders equity per share | -0.00 - | -1.41 3,223,670.63% | 1.15 181.50% | 0.73 36.25% | ||
stock based compensation to revenue | 0.01 - | 0.11 - | 0.05 57.51% | -0.07 246.63% | ||
tangible asset value | -17.63K - | -568.38M 3,223,670.63% | 535.08M 194.14% | 327.74M 38.75% | ||
tangible book value per share | -0.00 - | -1.41 3,223,670.63% | 1.15 181.50% | 0.73 36.25% | ||
working capital | -117.98K - | -5.63M 4,673.03% | 379.92M 6,846.89% | 184.34M 51.48% |
All numbers in (except ratios and percentages)